Loading...
Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of Small Cell Lung Cancer
With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...
Na minha lista:
Main Authors: | , |
---|---|
Format: | Artigo |
Sprog: | Chinês |
Udgivet: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-04-01
|
Serier: | Chinese Journal of Lung Cancer |
Fag: | |
Online adgang: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|